According to a new study released in RSNA’s June issue of the journal Radiology, doctors reported the combination of 2D and 3D mammography to be more effective at finding breast cancer compared to 2D alone. When it comes to fighting breast cancer, mammography screening is often considered the first line of defense. Many medical association... Read more
BILLERICA, Mass., June 4, 2018 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) announced today it will present at the following conferences: Jefferies 2018 Global Healthcare Conference, New York, NYThursday, June 7, 2018, at 8:30 a.m. Eastern TimeFrank Laukien, President and Chief Executive OfficerJuergen Srega, President, Bruker CALID Group William Blair 38th Annual Growth Stock Conference, Chicago,... Read more
SAN DIEGO, June 4, 2018 /PRNewswire/ — ASMS 2018 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled advances in its leading mass spectrometry portfolio that make these powerful technologies more accessible to scientists across life sciences and applied markets. New instruments, accessories and software deliver improved ease of use... Read more
SAN DIEGO, June 4, 2018 /PRNewswire/ — ASMS 2018 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today unveiled advances in its leading mass spectrometry portfolio that make these powerful technologies more accessible to scientists across life sciences and applied markets. New instruments, accessories and software deliver improved ease of use... Read more
Basel, 03 June 2018 Roche presents new data across a range of blood cancers at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting Further data demonstrate polatuzumab vedotin’s clinical efficacy across a range of diffuse large B-cell lymphoma subgroups Additional results from the randomised phase III MURANO study support fixed-duration Venclexta/Venclyxto plus MabThera/Rituxan... Read more
Basel, 02 June 2018 Phase III IMpower131 study showed Tecentriq(atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death for people with advanced squamous non-small cell lung cancer Data will be featured in the ASCO press programme on Saturday 2 June and presented at ASCO on Monday 4 June Roche (SIX:... Read more
Basel, 02 June 2018 Phase III IMpower131 study showed Tecentriq(atezolizumab) plus chemotherapy (carboplatin and Abraxane) reduced the risk of disease worsening or death for people with advanced squamous non-small cell lung cancer Data will be featured in the ASCO press programme on Saturday 2 June and presented at ASCO on Monday 4 June Roche (SIX:... Read more
Creating Access to the Power and Potential of Mass Spectrometry for More Laboratories MILFORD, Mass.–(BUSINESS WIRE)–Jun. 1, 2018– Waters (NYSE:WAT) is giving scientists attending ASMS 2018 a first look at new mass spectrometry technologies developed to serve the multi-faceted analytical requirements of food testing, university and biomedical research laboratories. The new products include a gas chromatography-mass spectrometry/mass spectrometry... Read more
FRANKLIN LAKES, N.J., June 1, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: Jefferies 2018 Global Healthcare ConferenceJune 8, 201810:00 a.m. EDT Goldman Sachs 38th Annual Global Healthcare ConferenceJune 13, 20188:40 a.m. EDT Live webcasts... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Jun. 1, 2018– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the 38th annual Goldman Sachs Global Healthcare Conference on Wednesday, June 13, 2018 at 2:00 p.m. PT at the Terranea Resort in Rancho Palos Verdes, Calif. Robert F.... Read more